In metastatic differentiated thyroid cancer (mDTC), Severson et al. found that Gal-9 was expressed in tumor-involved lymph nodes (TILNs), and Gal-9 may contribute to the dysfunction of PD-1+Tim3+CD8+ T cells, thus promote disease progression [30]. Here, LGALS9 is linked to neoplasm.